Canada Life
KRTX

Canada Life’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Canada Life’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,994
Closed -$941K – 2162
2023
Q4 		$941K Buy
2,994
+355
+13% +$69K ﹤0.01% 1522
2023
Q3 		$446K Buy
2,639
+1,400
+113% +$263K ﹤0.01% 1706
2023
Q2 		$270K Sell
1,239
-65
-5% -$13.9K ﹤0.01% 1800
2023
Q1 		$237K Sell
1,304
-113
-8% -$21.6K ﹤0.01% 1840
2022
Q4 		$280K Hold
1,417
– – ﹤0.01% 1833
2022
Q3 		$318K Buy
1,417
+370
+35% +$74.9K ﹤0.01% 1771
2022
Q2 		$132K Hold
1,047
– – ﹤0.01% 1877
2022
Q1 		$141K Hold
1,047
– – ﹤0.01% 1931
2021
Q4 		$137K Hold
1,047
– – ﹤0.01% 1944
2021
Q3 		$129K Hold
1,047
– – ﹤0.01% 1999
2021
Q2 		$119K Buy
1,047
+156
+18% +$18.2K ﹤0.01% 2044
2021
Q1 		$106K Hold
891
– – ﹤0.01% 2089
2020
Q4 		$90K Hold
891
– – ﹤0.01% 2140
2020
Q3 		$69K Hold
891
– – ﹤0.01% 2115
2020
Q2 		$99K Buy
+891
New +$77.5K ﹤0.01% 2045

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Canada Life's KRTX Position: Q1 2024 in Review

Canada Life sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 2,994 shares — an estimated $941K sold.

Canada Life first reported a position in KRTX in Q2 2020 and held it in 15 quarters. The position peaked at $941K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Canada Life reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Canada Life sold 2,994 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $941K.
  • Canada Life first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2020 and held it in 15 quarters.
  • Canada Life's Karuna Therapeutics, Inc. Common Stock position peaked at $941K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Canada Life's 13F filing for Q1 2024, filed 13 May 2024.